2025. Belimumab in Lupus Nephritis Patients with Impaired Renal Function: A Post-Hoc Analysis of the Bliss-LN Trial. Epidemiology, Biostatistics, and Public Health. (Sep. 2025). DOI:https://doi.org/10.54103/2282-0930/29538.